Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies
Elisa ten Hacken(Harvard University), Catherine J. Wu(Dana-Farber Cancer Institute), Donna Neuberg(Otsuka (Japan)), Jing Sun(Dana-Farber Cancer Institute), Laura Z. Rassenti(University of California San Diego), Michaël Thomas(Queen Alexandra Hospital), Anthony Letai(Dana-Farber Cancer Institute), Ruben D. Carrasco(Brigham and Women's Hospital), Lillian Werner(Dana-Farber Cancer Institute), Thomas J. Kipps(University of California San Diego), Robin Reed(Harvard University), Silvia Buonamici(New York University), Amy Gill(Dana-Farber Cancer Institute), Peter G. Smith(Kenya Medical Research Institute), Pavan Bachireddy(Broad Institute), Jan A. Burger(The University of Texas MD Anderson Cancer Center), Matthew S. Davids(Dana-Farber Cancer Institute), Jing Deng(Guangdong Provincial Center for Disease Control and Prevention), Shanye Yin(Albert Einstein College of Medicine), Michaela Gruber(Dana-Farber Cancer Institute), Emanuela M. Ghia(University of California San Diego), Fara Faye Regis(Dana-Farber Cancer Institute), Angela N. Brooks(University of California, Santa Cruz), Mei Zheng(Guangzhou Women and Children Medical Center), Jessica Wong(Dana-Farber Cancer Institute), Lili Wang(Shanghai Jiao Tong University), Rebecca Valentin(Dana-Farber Cancer Institute), Michael Seiler(Rutgers, The State University of New Jersey), Ekaterina Kim(The University of Texas MD Anderson Cancer Center)
Cited by 52
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k